Literature DB >> 10389177

Transduction and transmission properties of primary nociceptive afferents.

R D Treede1.   

Abstract

The prototypical primary nociceptive afferent is the polymodal C-fiber nociceptor, which responds to noxious thermal, mechanical, and chemical stimuli. C-fiber nociceptors are peripheral terminals of small neurons in the dorsal root ganglia (DRG). DRG neurons must therefore supply their peripheral terminals with the molecular machinery for the encoding of noxious stimuli into trains of action potentials. The following phenomena are known for this encoding process in vivo: 1) adaptation: for a constant stimulus intensity the action potential discharge decreases slowly within 2-3 seconds, 2) fatigue: recovery from adaptation may take ten minutes or more, 3) sensitization: preceding tissue damage enhances the response, particularly to heat stimuli. Recent studies in vitro have provided important clues about the molecular mechanisms underlying these phenomena. Several membrane receptors and channels are specifically expressed in small nociceptive neurons, such as vanilloid receptors (VR1), purinergic receptors (P2X3), acid sensing ion channels (ASIC), and TTX-resistant Na-channels. In the near future, we may therefore expect major advances in our understanding of the transduction of noxious stimuli into generator potentials and transformation into trains of action potentials. Along the axon that leads from the innervated tissue to the spinal cord, primary nociceptive afferents have a limited capacity to transmit high impulse rates, suggesting a different composition of voltage-gated channels than in other primary afferents (low-threshold mechanoreceptors and thermoreceptors). Finally, the DRG neuron also supplies its central terminals with the molecular machinery for synaptic transmission and its presynaptic modulation. Progress in understanding the cellular mechanisms at both ends of the primary nociceptive neuron promises to lead to new analgesic treatment modalities for both acute and chronic pain.

Entities:  

Mesh:

Year:  1999        PMID: 10389177

Source DB:  PubMed          Journal:  Ross Fiziol Zh Im I M Sechenova        ISSN: 0869-8139


  8 in total

Review 1.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

2.  Interaction of intensity and order regarding painful events.

Authors:  Brandon N Kyle; Daniel W McNeil; Benjamin J Weinstein; James D Mark
Journal:  J Behav Med       Date:  2009-03-12

3.  Chemosensory signal transduction in Caenorhabditis elegans.

Authors:  Denise M Ferkey; Piali Sengupta; Noelle D L'Etoile
Journal:  Genetics       Date:  2021-03-31       Impact factor: 4.562

4.  Offset analgesia: a temporal contrast mechanism for nociceptive information.

Authors:  Marc D Yelle; June M Rogers; Robert C Coghill
Journal:  Pain       Date:  2007-05-29       Impact factor: 6.961

5.  Analgesic effect of piracetam on peripheral neuropathic pain induced by chronic constriction injury of sciatic nerve in rats.

Authors:  Ashish K Mehta; Yogendra Bhati; Chakra D Tripathi; Krishna K Sharma
Journal:  Neurochem Res       Date:  2014-05-16       Impact factor: 3.996

6.  Isolated nociceptors reveal multiple specializations for generating irregular ongoing activity associated with ongoing pain.

Authors:  Max A Odem; Alexis G Bavencoffe; Ryan M Cassidy; Elia R Lopez; Jinbin Tian; Carmen W Dessauer; Edgar T Walters
Journal:  Pain       Date:  2018-11       Impact factor: 7.926

Review 7.  Brain imaging of pain: state of the art.

Authors:  Debbie L Morton; Javin S Sandhu; Anthony Kp Jones
Journal:  J Pain Res       Date:  2016-09-08       Impact factor: 3.133

8.  Touch inhibits subcortical and cortical nociceptive responses.

Authors:  Flavia Mancini; Anne-Lise Beaumont; Li Hu; Patrick Haggard; Gian Domenico D Iannetti
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.